Patent · US Active

Soluble IGF receptor Fc fusion proteins and uses thereof

US10538575B2 · kind B2 · utility

0Cited by

2References

13Claims

0Family size

Inventors

Pnina Brodt · Montréal, CA
Bernard Massie · Laval, CA
Traian Sulea · Kirkland, CA

Key dates

Filing date	Dec 14, 2012
Grant date	Jan 21, 2020
Priority date	—
Expiry date	Apr 2, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There are described herein novel soluble IGF receptor Fc fusion proteins and compositions and methods of use thereof for treating angiogenesis associated disorders and malignant disease, such as cancer and metastasis, wherein the fusion proteins bind specifically to IGF-1 or IGF-2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.